Drugs / Polysporin
last change Oct 2021 re-read 2 minutes ago

Polysporin

Developed for
actinic keratosis
Investigated by
Wake Forest University

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) POLYSPORIN 1974-04-16 fda.gov

Trials 1 · a red edge is where a trial was stopped

today
US approved 1974
NCT00695578 · Ph 4
19731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00695578 Oct 2006 → Jun 2007 actinic keratosis Wake Forest University Completed No outcome recorded
Also used as a comparator or background therapy in 3 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/22 trials
Phase 1/2 NCT05000983 Comparator Oct 2021 → Nov 2028 expected University of Manitoba Recruiting No outcome recorded
Phase 1/2 NCT04893863 Comparator Oct 2021 → Dec 2028 expected University of Manitoba Recruiting No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT00674999 Comparator Jun 2005 → Sep 2008 The University of Texas Medical Branch, Galveston Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Polysporin “Topical antibiotic ointment (Polysporin™ or formulary equivalent) and non-adherent petrolatum fine-meshed gauze (ADAPTIC™) applied every Monday, Wednesday and Friday (or equivalent).” NCT04893863
3

“Topical antibiotic ointment (Polysporin™ or formulary equivalent)” NCT05000983

NCT00674999

NCT00695578

Route Topical “over the counter Polysporin ointment 3 times daily for 4 weeks to wounds” NCT00695578